{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T19:16:53Z","timestamp":1784747813828,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clml.2021.12.006","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T17:24:08Z","timestamp":1639243448000},"page":"e376-e385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"22","author":[{"given":"Naglaa M.","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona S.","family":"Abdellateif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas M.","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Abed","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman D. El","family":"Desouky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-3096","authenticated-orcid":false,"given":"Mahmoud M.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah M.","family":"Gameel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2021.12.006_bib0001","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.clml.2016.02.032","article-title":"Immunophenotypic characterization of cytogenetic subgroups in egyptian pediatric patients with B-cell acute lymphoblastic leukemia","volume":"16","author":"Adnan Awad","year":"2016","journal-title":"Clinical Lymphoma, Myeloma and Leukemia"},{"key":"10.1016\/j.clml.2021.12.006_bib0002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.beha.2017.07.003","article-title":"The biology of Philadelphia chromosome-like ALL","volume":"30","author":"Roberts","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.clml.2021.12.006_bib0003","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0004","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","article-title":"Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.leukres.2015.11.018","article-title":"CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities","volume":"41","author":"Chiaretti","year":"2016","journal-title":"Leuk Res"},{"issue":"1","key":"10.1016\/j.clml.2021.12.006_bib0006","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/ijlh.13012","article-title":"BCRABL1- Like B-lymphoblastic leukemia\/lymphoma: Review of the entity and detection methodologies","volume":"41","author":"Conant","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.clml.2021.12.006_bib0007","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4049\/jimmunol.179.2.1068","article-title":"Stat5 is essential for early B cell development but not for B cell maturation and function","volume":"179","author":"Dai","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.clml.2021.12.006_bib0008","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/gcc.22421","article-title":"Prognostic significance of P2RY8-CRLF2 and CRLF2 overexpression may vary across risk subgroups of childhood B cell acute lymphoblastic leukemia","volume":"56","author":"Dou","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.clml.2021.12.006_bib0009","first-page":"11555","article-title":"Prevalence of the frequency of JAK2 (V617F) mutation in different myeloproliferative disorders in Egyptian patients","volume":"8","author":"Ebid","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/j.clml.2021.12.006_bib0010","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1182\/blood-2018-99-113471","article-title":"Poor Outcome of CRLF2 Rearranged Philadelphia negative acute lymphoblastic leukemia adults patients","volume":"132","author":"Elnahass","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0011","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1182\/blood-2010-07-297135","article-title":"Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial","volume":"117","author":"Ensor","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2021.12.006_sbref0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/10428194.2016.1180682","article-title":"IKZF1 alterations and expression of CRLF2 predict prognosis in adult Chinese patients with B-cell precursor acute lymphoblastic leukemia","volume":"58","author":"Fang","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2021.12.006_bib0013","article-title":"TSLP\u2011induced mechanisms and potential therapies for CRLF2 B\u2011cell acute lymphoblastic leukemia","volume":"282","author":"Francis","year":"2015"},{"key":"10.1016\/j.clml.2021.12.006_bib0014","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1200\/JCO.2016.70.7836","article-title":"Genetic Basis of Acute Lymphoblastic Leukemia","volume":"35","author":"Iacobucci","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.12.006_bib0016","first-page":"885","article-title":"Potential efficacy and prognosis of silencing the CRLF2\u2011mediated AKT\/mTOR pathway in pediatric acute B\u2011cell lymphoblastic leukemia","volume":"41","author":"Jiang","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clml.2021.12.006_bib0017","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1200\/JCO.2011.40.3907","article-title":"IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia","volume":"30","author":"Moorman","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2021.12.006_bib0018","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B progenitor\u2013 and Down syndrome\u2013associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.clml.2021.12.006_bib0019","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl AcadSci U S A"},{"key":"10.1016\/j.clml.2021.12.006_bib0020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3324\/haematol.2015.131680","article-title":"Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome","volume":"101","author":"Oskarsson","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2021.12.006_bib0021","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2012.101","article-title":"Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia","volume":"26","author":"Palmi","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.12.006_bib0022","doi-asserted-by":"crossref","first-page":"25971","DOI":"10.18632\/oncotarget.25411","article-title":"Surface expression of cytokine receptor-like factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions","volume":"9","author":"Pastorczak","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2021.12.006_bib0023","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41375-021-01133-4","article-title":"Increased Incidence of IKZF1 deletions and IGH-CRLF2 translocations in B-ALL of Hispanic\/Latino children-a novel health disparity","volume":"35","author":"Raca","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2021.12.006_bib0024","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2020.200414","article-title":"Characterization of CRLF2 Expression in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"67","author":"Rasekh","year":"2021","journal-title":"Clin Lab"},{"key":"10.1016\/j.clml.2021.12.006_bib0025","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable kinase gene fusions in high-risk B-ALL: a study from the children's oncology group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.clml.2021.12.006_bib0026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s12288-020-01295-8","article-title":"Recent advances in molecular diagnosis and prognosis of childhood B cell lineage acute lymphoblastic leukemia (B-ALL)","volume":"37","author":"Agarwal","year":"2020","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.clml.2021.12.006_bib0027","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in acute lymphoblastic leukaemia: insights and treatment implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clml.2021.12.006_bib0028","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0029","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-020-0308-3","article-title":"A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics","volume":"10","author":"S\u00e1nchez","year":"2020","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.clml.2021.12.006_bib0030","doi-asserted-by":"crossref","first-page":"e26539","DOI":"10.1002\/pbc.26539","article-title":"Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood","volume":"64","author":"Schm\u00e4h","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clml.2021.12.006_bib0031","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.3390\/ijms21062193","article-title":"The current genomic and molecular landscape of philadelphia-like acute lymphoblastic leukemia","volume":"21","author":"Shiraz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clml.2021.12.006_bib0032","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clml.2021.12.006_bib0033","doi-asserted-by":"crossref","first-page":"89923","DOI":"10.18632\/oncotarget.21027","article-title":"JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia","volume":"8","author":"Steeghs","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clml.2021.12.006_bib0034","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0035","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood-2017-06-743252","article-title":"Philadelphia chromosome-like acute lymphoblastic leukemia","volume":"130","author":"Tasian","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0036","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value ofBCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clml.2021.12.006_bib0037","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12885-021-08635-5","article-title":"Clinical application of whole transcriptome sequencing for the classification of patients with acute lymphoblastic leukemia","volume":"21","author":"Walter","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2021.12.006_bib0038","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/gcc.22190","article-title":"An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpression","volume":"53","author":"Yano","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2021.12.006_bib0039","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1073\/pnas.0911726107","article-title":"Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia","volume":"107","author":"Yoda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.clml.2021.12.006_bib0040","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3324\/haematol.2018.204974","article-title":"Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021024757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265021024757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T13:58:35Z","timestamp":1682949515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265021024757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2152265021024757"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2021.12.006","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic significance of CRLF2 overexpression and JAK2 mutation in Egyptian pediatric patients with B-precursor acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}